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The preparation of biotinylated, self-assembled polymer stabilized gold nanoparticle hybrids 
encoded with a SERS active compound is described. The polymers used for nanoparticle 
stabilization are carefully designed for this purpose and are synthesized by the RAFT 
polymerization process, as the thiocarbonylthio end group provides a functional handle for 
anchoring the polymers to the gold surface. Functionalized biotin moieties are attached to the 
hybrid nanoparticles via Cu-catalyzed azide-alkyne cycloaddition. Binding of the biotinylated 
hybrid nanoparticles to streptavidin was confirmed by nanoparticle detection and identification 
by the SERS spectrum of the surface-bound SERS active compound, quinoline thiol. This 
investigation includes the requisites that constitute a bioassay, demonstrating the potential of 
polymer-coated hybrid nanoparticles for this purpose.  
Introduction 
Fluorescence labelling has found considerable use for detection 
of binding events in bioassays due to its inherent sensitivity and 
ease of implementation.1 However, due to broad intrinsic band 
widths, the number of analytes in an assay is limited. 
Fluorescence labelling also has other inherent problems, 
including autofluorescence of the substrate, photobleaching of 
the dyes, and the need to use multiple excitation sources.2-4 An 
alternative strategy for bioassays is based on gold nanoparticles 
(AuNPs), with surface enhanced Raman spectroscopy (SERS) 
as the detection technique. SERS has the potential for greater 
specificity than fluorescence and does not suffer from the 
obstacles noted above.2-5 The narrow bandwidths associated 
with the SERS technique (~20 cm-1) provides the potential to 
achieve much greater levels of multiplexing than is possible 
with fluorescence, significantly improving the prospects for 
increased assay throughput. Recently, a number of papers have 
reported the use of AuNPs labelled with a SERS active 
compound (SAC) for use in protein bioassays.2-7 The function 
of the SAC is to detect and also differentiate between different 
AuNPs and has been likened to a “molecular barcode”. The use 
of NPs brings its own problems, the most important of which is 
the poor long-term stability of the NP suspensions. Our strategy 
to overcome this has been to prepare SAC-encoded AuNPs 
stabilized by RAFT polymers,8 through surface binding of the 
polymer to Au via the thiocarbonylthio group.9-19  
 Here we demonstrate a model bioassay in which binding to
 a streptavidin substrate is detected by SERS. This was 
achieved through the synthesis of polymer stabilized AuNPs 
functionalized with a biotin moiety, introduced through the 
polymer end-group. A schematic of this strategy is given in 
Figure 1. Whilst biotinylated polymer-stabilized AuNPs have 
been previously in the literature,17 with turbidity of the solution 
used to detect a binding event to avidin, detection of the event 
by SERS as described herein provides more definitive proof  of 
bioconjugation. 
 There are a number of approaches for the synthesis of 
polymers with defined architecture; one of the most successful 
in recent years has been the reversible addition-fragmentation 
chain transfer (RAFT) process.18, 19 RAFT polymerization is 
applicable to a wide range of monomers and, under appropriate 
conditions, produces polymers with controlled molecular 
weight and low dispersity. These properties are brought about 
by use of a thiocarbonylthio chain transfer (or RAFT) agent.20 
 A feature of RAFT polymerization is the conservation of 
the thiocarbonylthio functionality as the -end-group in the 
final polymer (see Scheme 1). This provides a functional 
handle in which to incorporate additional functionality.21, 22 The 
polymers were designed to have one end-group (‘ZCS2’) to 
specifically bind to the surface of the AuNPs, pendant 
polyethyleneglycol (PEG) chains, which exhibit low non-
specific binding and the α-end-group (‘R’ group) carries an 
alkyne functionality, amenable to the Cu-catalyzed click 
reaction, which can be used to attach biologically active 
moieties required for bioassays. 
 
Figure 1: Schematic showing the assembly of hybrid NPs for use in bioassays with SERS detection 
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 Scheme 1: Generic scheme for RAFT polymerization 
 
Results and discussion  
For the assembly of the hybrid nanoparticles, we targeted the 
synthesis of a polymer containing poly(ethylene glycol) (PEG) 
pendant groups through the RAFT polymerization of PEG 
methacrylate (PEGMA), because PEG is both water soluble and 
inhibits non-specific binding to proteins.23  
RAFT Agent Synthesis 
To introduce alkyne functionality in the polymer end-group, we 
prepared prop-2-ynyl 2-phenyl-2-
(phenylcarbonothioylthio)acetate (5), bearing the secondary 
benzylic propargyl ester ‘R’ group in moderate yield over two 
steps. Benzylic esters24, 25 allow for simple introduction of end-
group functionality whilst delivering control over the 
polymerization of methacrylic monomers.22, 23 Esterification of 
α-bromophenylacetic acid 1 with propargyl alcohol using DCC 
coupling gave the bromo ester 2 in 37 % yield (see Scheme 2). 
Subsequent reaction with benzodithioate salt 4 (prepared from 
PhMgBr 3 and CS2) gave the alkyne functional dithiobenzoate 
RAFT agent 5 in 38 % yield. 
RAFT Polymerization  
Polymerization of PEGMA Error! Reference source not found., 
in the presence of the acetylene RAFT agent Error! Reference 
source not found., gave low dispersity alkyne-functional 
poly(PEGMA) Error! Reference source not found. after 
purification by precipitation (Mn = 7800, Đ = 1.10) (see 
Scheme 3). The presence terminal acetylene unit is evident 
through 1H NMR. This functional group readily undergoes a 
regioselective reaction with azide functionalized molecules via 
a copper-catalyzed azide-alkyne cycloaddition. (CuAAC).20 
Synthesis of Azido-Functional Biotin 
To facilitate functionalization of the polymer with a biotin 
 
Scheme 2: Synthesis of Alkyne-Functional RAFT Agent Error! 
Reference source not found. 
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moiety, the synthesis of an azido-functionalized biotin analogue 
was undertaken. For this purpose, 4-(5-azidopentyl)tetrahydro-
1H-thieno[3,4-d]imidazole-2(3H)-one (12) can be synthesized 
from readily available d-biotin 8 (see Scheme 4). Fischer 
esterification of d-biotin27 8 provides the ethyl ester 9 in high 
yield (74 %).  Subsequent reduction with diisobutylaluminium 
hydride (DIBAL)27 furnished the alcohol, biotinol 10 in 71 % 
yield. Attempted tosylation in anhydrous pyridine resulted in a 
mixture of the tosylate 11a (19 %) and chloride 11b (16%) (35 
% combined yield). This appearance of the chloro species 11b 
in the reaction of biotinol with sulfonyl chlorides has been 
previously observed by Islam et al.28 In this report the treatment 
of biotinol with methanesulfonyl chloride gave both the 
mesylate and chloride. Use of excess pyridine in the tosylation 
reaction, in our case by its use as solvent, can facilitate 
formation of chloro species by reaction of the pyridinium 
chloride by-product with the newly formed tosylate.29 
Nevertheless, nucleophilic substitution of this mixture 11 with 
NaN3 in DMF delivered the requisite biotin azide 12 in 
moderate yield (62 %) (see Scheme 4 for synthetic route). This 
compound was then used to create the biotinylated polymer. 
 
Scheme 3: Synthesis of Alkyne-Functional poly(PEGMA) via RAFT polymerization  
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 Scheme 4: Synthesis of Azido-Functional Biotin 12 
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Polymer-Biotin Conjugation via “Click” Chemistry  
Successful coupling of the biotin azide 12 to the alkynyl 
functional (poly)PEGMA 7 was achieved via CuAAC (Scheme 
5). The progress of the reaction could be observed by a colour 
change from a pale pink (the colour of the polymer brought 
about the chromophore of the RAFT end group) to a dark 
brown, due to a change in oxidation state of the Cu (II) to Cu 
(0) (from disproportionation of Cu(I)). The reaction was 
monitored for completion using ATR-IR spectroscopy, which 
clearly showed the complete loss of the distinctive azide 
stretching band near 2100 cm-1 (see Figure 2). Note the band 
appearing at 3200 cm-1 is due to the water present. Purification 
of the biotinylated polymer 13 was achieved by centrifugation 
of the reaction mixture, removal of the supernatant and 
resuspension, which was performed in triplicate. The final 
centrifugation step provided the purified polymer as aqueous 
solution. 
Scheme 4: Polymer-Biotin Conjugation via CuAAC 
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Figure 2: ATR-IR spectra of (a) poly(PEGMA) 7 (b) biotin 
azide (12) (c) initial reaction mixture of biotin azide 42 and 
poly(PEGMA) 7 and (d) reaction mixture of 7 and 12 after 2h.  
The disappearance of the azide peak at 2089 cm-1 is noted by 
the arrow. 
Self-Assembly of Biotinylated Polymer Stabilised AuNPs and 
Tagging with SAC  
The self-assembly of the hybrid NPs was achieved by addition 
of the aqueous solution of biotinylated polymer 13 from above 
into an aqueous citrate stabilized AuNPs solution. The resulting 
polymer stabilized AuNPs could be subsequently phase 
transferred into chloroform, as reported previously,8 for 
simplified isolation. Importantly, this method allows the phase 
transfer of hydrophilic AuNPs after their encapsulation by a 
more hydrophobic polymer, without the addition of a phase 
transfer agent, allowing for the easy removal of citrate and 
other unwanted contaminants. The hybrid AuNPs were isolated 
from chloroform by removal of solvent and resuspended in 
water. Addition of the SAC, 2-quinolinethiol (QSH) to the 
aqueous solution resulted in the QSH tagged AuNPs. 
Successful polymer encapsulation of the AuNPs can be seen in 
the TEM micrograph (see Figure 3). 
Stability Assessment of Hybrid AuNPs 
The stability of the polymer-stabilized hybrid AuNPs was 
assessed by a comparison between alkyne functional polymer 
hybrid AuNPs and citrate-stabilized AuNPs after addition of 
saturated sodium chloride (NaCl) solution. NaCl is expected to 
destabilize AuNPs because of the rapid change in solubility of 
the nanoparticles.   
 
Figure 3: Representative TEM micrograph image of polymer 
stabilised AuNPs 
 The citrate stabilized AuNPs showed complete 
destabilization on addition of NaCl, indicated by a colour 
change from bright pink/purple in solution to black (a sign of 
aggregation) immediately after the NaCl addition.  Within a 
few minutes the now aggregated AuNPs precipitated leaving a 
black film on the bottom of the vessel. The presence of a 
colourless supernatant indicated the absence of AuNPs in 
solution. An example of irreversible aggregation is show in 
Figure S3 in the supporting information. In stark contrast, the 
addition of NaCl solution did not affect the stability of hybrid 
AuNPs; that is no colour change was observed and no change 
in the surface Plasmon resonance (SPR) was detected by visible 
spectroscopy. These observations illustrate that the hybrid 
AuNPs have considerably enhanced stability compared to 
citrate stabilized AuNPs. 
Bioconjugation of Streptavidin 
Due to the remarkable binding affinity of biotin to 
streptavidin,21 the interaction between this protein-ligand pair 
has become a commonly used method of bioconjugation.22  To 
illustrate the potential of polymer stabilized NPs for use as 
detection modalities in bioassays, SERS detection of a binding 
event between streptavidin and the biotinylated hybrid AuNPs 
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was undertaken. As streptavidin possesses several biotin 
binding sites, the AuNPs were expected to precipitate from 
solution following the addition of the streptavidin.  Whilst 
precipitation was observed experimentally, this did not provide 
definitive proof a binding event had taken place. Alternatively 
the aggregation may be due to the presence of a salt or another 
destabilizing agent.  
 Since we required further evidence of detection of the biotin 
streptavidin binding to illustrate the viability of our AuNP 
system for bioassay application, an assay where streptavidin is 
surface-bound (an ELISA-like assay)23 was also undertaken. 
For this process a solution of the biotinylated AuNPs was 
washed over a streptavidin functionalized surface. The surface 
was subsequently washed with water to remove any AuNPs 
adsorbed to (but not bound to) the surface. Binding was 
confirmed by SERS. AuNPs without biotin conjugation was 
compared as a negative control.  
 Figure 3 shows the SERS spectra of the RAFT end-group 
(a) the SAC 2-quinolinethiol (b), and the Raman spectrum of 
polystyrene well plate (c). It can be seen that the SERS 
spectrum obtained from the well plate after treatment with the 
hybrid AuNPs (Figure 3 (d)) contains bands around 790, 1080, 
1330 and 1380 cm-1 which accord well with the SERS 
spectrum of the SAC, 2-quinolinethiol (Figure 3(b)). There 
were also additional bands, such as the intense band near 1000 
cm-1 together with weaker bands at 1050, 1210 and 1600 cm-1, 
which correspond well with the SERS spectrum of the RAFT 
group. We have recently shown that related phenyldithioesters 
interact strongly with the AuNP surfaces through the C=S bond 
RAFT endgroup.24 In the spectrum shown in Figure 3 (a), the 
intense band near 1000 cm-1 can be assigned to the ring 
breathing mode of the aromatic ring, while the less intense 
bands at 1050, 1210 and 1600 cm-1 can be assigned to υC-S, 
υC=S and the C=C stretch of the aromatic ring, respectively. 
Additional contribution obtained from the polystyrene substrate 
can also be observed in the SERS spectrum of the biotin-
streptavidin surface bound AuNPs (Figure 3 (d)).  
 The binding experiment described above was repeated using 
hybrid NPs which were composed of PEGMA which had not 
been biotinylated, but did incorporate the SAC, 2-
quinolinethiol. After washing the well plate in the same way the 
Raman spectrum did not reveal any bands due to the hybrid 
AuNPs, either from the SERS spectrum of the RAFT end-
group, or from the SAC. This indicated that, as expected, in the 
absence of the biotin moiety there is no binding to the 
immobilized streptavidin and the hybrid AuNPs were removed 
from the well during the washing procedure.  
 Whilst the SERS spectrum of the bound hybrid AuNPs 
contains bands due to the polystyrene substrate, the existence of 
the SERS spectrum of the SAC is clear. At least four significant 
bands can be seen and their positions uniquely identify both the 
presence and identity of the hybrid AuNPs.   
 In order to further illustrate that the binding event occurred, 
confocal Raman microscopy was employed to examine the 
change in intensity of the SERS signal of both the SAC and the 
RAFT agent, in comparison to the polystyrene substrate.  The 
SERS spectra at varying depths of laser penetration are shown 
in Figure 4, with the peaks arising from each analyte labelled in 
the same fashion as for Figure 3 (RAFT = R; quinolinethiol = 
Q; polystyrene = PS; labels are shown above the top spectrum 
only for clarity). The SERS spectrum of the surface bound NPs, 
measured at the laser focus depth that gave maximum signal  
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Figure 3: SERS spectra of (a) RAFT end group of 13, (b) 2-
quinolinethiol, (c) Raman spectrum of the well plate’s 
polystyrene substrate, and (d) the SERS spectrum after the 
binding event; the major peaks corresponding to the RAFT end-
group of 13, 2-quinolinethiol and polystyrene substrate are 
labelled as R, Q and PS respectively and numbered for ease of 
correlation. 
intensity for the SAC and RAFT agent peaks is shown in Figure 
4 (a). When the depth of focus of the laser was varied from this 
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position, then the signal intensity varied. As the depth of focus 
was moved 50 µm toward the substrate the PS peak at 1000 
cm-1 (PS1) becomes more prominent, indicated by a change in 
the relative peak intensity compared to the peak arising from 
the RAFT group at approximately 1200 cm-1 (R2) (see Figure 4 
(b)). The bare PS substrate is shown for comparison in Figure 4 
(c).  
 The change in relative intensity of the peaks at 1000 cm-1 
and 1200 cm-1 suggests there is a contribution to the signal at 
1000 cm-1 arising from the PS substrate. In spite of this, the 
SERS signals from the RAFT group and the SAC are easily 
observed in Figure 4 (a) and clearly illustrate successful 
binding of the biotinylated AuNPs to the streptavidin 
functionalized surface.  
 These results illustrate the potential utility of our SERS 
detected hybrid AuNP system for use in both precipitation and 
ELISA-like surface bound assays. The advantages of each 
assay type can be exploited through their use: (a) the simplicity 
of precipitation assays and (b) the sensitivity of the 
ELISA/surface binding method.  
Conclusions 
In summary, we have synthesized biotinylated polymer-
stabilized hybrid AuNPs incorporating a SAC, 2-quinolinethiol. 
This material interacts strongly with streptavidin immobilized 
on a polystyrene surface and this binding can be detected by the 
SERS spectrum of the SAC. Binding to streptavidin was not 
observed for hybrid AuNPs which did not contain the biotin 
moiety, and no SERS spectrum was observed. The sequence of 
reactions discussed in this paper constitutes a bioassay and 
hence demonstrates the potential for hybrid AuNPs, using 
tailored polymers, to be used as a novel approach to bioassays, 
with SERS as the detection method. The illustration of this 
procedure in multiplexing experiments will be the focus of 
future investigations. 
Experimental  
Materials: Unless otherwise stated, all reagents and solvents were 
used as received.  All water used was MilliQ Ultrapure 18 MΩ cm. 
SigmaScreen™ Streptavidin High Capacity Coated Plates and all 
chemicals were purchased from Sigma Aldrich, with the exception 
of streptavidin and biotin that were purchased from Anaspec. 
Characterization: 1H Nuclear Magnetic Resonance (NMR) 
spectra were collected using a 5 mm BBOz gradient probe at 
298 K on the Bruker Avance 300 MHz and 13C spectra were 
collected using a 5mm SEIz probe at 298K on the Bruker 
Avance 400 MHz. Deuterated solvents for NMR spectroscopy 
were commercially obtained (Cambridge Isotopes) and were of 
99.8 atom % D. Chemical shifts () are reported in parts per 
million (ppm) relative to residual solvents.25 Gel permeation 
chromatography (GPC) measurements of the polymers were 
performed using a Waters Alliance 2690 Separations Module 
equipped with an autosampler, column heater, differential 
refractive index detector and a Photo Diode Array (PDA) 
connected in series. HPLC grade tetrahydrofuran was used as 
the eluent at a flow rate of 1 mL min-1. The columns consisted 
of three 7.8 x 300 mm Waters Styragel SEC columns connected 
in series, comprising of two linear Ultrastyragel and one 
Styragel HR3 columns. Polystyrene standards ranging from 
2000000-517 g mol-1 were used for calibration and all GPC 
derived molecular weights are quoted in polystyrene 
equivalents. Raman spectra were recorded with a Renishaw  
  
 
 
Figure 4: Depth profile confocal Raman microscopy spectra measured at (a) the depth of maximum Raman peak intensity, (b) 50 
µm toward the substrate from the point of maximum signal intensity, and (c) the polystyrene substrate.  
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 Model 1000 micro Raman spectrometer (Renishaw plc, Wotton-
under-Edge, UK) equipped with a 785 nm excitation source from a 
diode laser, a single diffraction grating and an electrically cooled 
CCD detector. A 10 % neutral density filter was used, which resulted 
in a laser power at the sample of about 1 mW. A single accumulation 
in the spectral range 2000–200 cm-1 was collected for each sample. 
Confocal mode with a pinhole inserted was used for measurements 
taken on the streptavidin well plate. Transmission Electron 
Microscopy (TEM) micrographs were imaged on a JEOL 1200 
TEM, where the energy was set to 80 kV and spot size 3. Solutions 
of citrate AuNPs in water and solutions of polymer stabilised AuNPs 
in chloroform were dropped onto carbon-celloidin coated 200-mesh 
copper TEM grids and allowed to dry before placing in TEM sample 
holder.  Citrate stabilised AuNPs that were dispersed in water, were 
synthesised using the citrate method.26, 27 Size of the nanoparticles 
was confirmed on a Joel 1200 TEM. TEM micrographs of AuNPs 
synthesised by the citrate method were analysed and average size 
was taken.  Samples were mounted on celloidin – carbon coated 200 
mesh copper grids. It should be noted that the NPs aggregated on the 
carbon coated TEM grids during sample preparation. Attenuated 
Total Reflectance - Fourier Transform Infrared (ATR-FTIR) spectra 
were obtained on a Nicolet Nexus 5700 FTIR spectrometer equipped 
with a Nicolet Smart Orbit single bounce, germanium ATR 
accessory (Thermo Electron Corp., Waltham, MA). Spectra were 
recorded at 4 cm-1 resolution for at least 32 scans with an OPD 
velocity of 0.6289 cm s-1. Solids were pressed directly onto the Ge 
internal reflection element of the ATR accessory without further 
sample preparation. Spectra were manipulated using the OMNIC 7 
software package (Thermo Electron Corp., Waltham, MA).  
Synthesis of prop-2-ynyl 2-phenyl-2-
(phenylcarbonothioylthio)acetate (acetylene RAFT agent, 5) 
Part 1: Esterification reaction (synthesis of prop-2-ynyl 2-bromo-2-
phenylacetate, 2) 
Propargyl alcohol (1.21 g, 21.62 mmol, 1 equiv) was dissolved in 
DCM (12.5 mL). α-Bromophenylacetic acid  (5.58 g, 25.93 mmol, 
1.2 equiv) and 4-(dimethylamino)pyridinium 4-toluenesulfonate 
(DPTS) (1.27 g, 4.32 mmol, 0.2 equiv) were then added to the 
solution.  N,N’-Dicyclohexylcarbodiimide (DCC) (6.69 g, 32.40 
mmol, 1.5 equiv) was dissolved in a separate flask in DCM (12.5 
mL) and then transferred slowly to the reaction vessel. Upon 
addition of the DCC, the reaction mixture became cloudy as DCC 
urea was produced. The reaction was stirred overnight at room 
temperature under Ar to ensure completion, after which the reaction 
mixture was filtered to remove the precipitate.  The DCM solvent 
was removed under vacuum leaving an oily yellow residue. This was 
purified by column chromatography (SiO2, eluent: n-hexane) to give 
the desired propargyl ester 2 as a clear, colourless oil (1.97 g, 8.0 
mmol, 37 %); 1H NMR (400 MHz, CDCl3) δ ppm 2.54 (1H, t, J = 
2.3 Hz, C≡CH), 4.76 (1H, dd, J = 2.3 and 15.3 Hz, HCHC≡CH), 
4.82 (1H, dd, J = 2.3 and 15.3 Hz, HCHC≡CH), 5.42 (1H, s, CBrH), 
7.34-7.44 (3H, m, ArH), 7.54-7.61 (2H, m, ArH), 13C NMR (100 
MHz, CDCl3) δ ppm 45.9 (alkyl C), 53.7 (alkyl C), 75.8 (C≡C), 76.5 
(C≡C), 128.6 (ArC), 128.8 (ArC), 129.4 (ArC), 135.1 (ArC), 167.5 
(C=O) 
 
Part II: Synthesis of acetylene RAFT agent (prop-2-ynyl 2-phenyl-2-
(phenylcarbonothioylthio)acetate, 5)  
Phenyl magnesium bromide (PhMgBr), was prepared by placing 
pre-dried magnesium (0.561 g, 23.38 mmol, 3 equiv) and a couple of 
small crystals of iodine in a 50 mL oven-dried two-neck round-
bottomed flask. The flask was then attached to a Schlenk manifold 
via a reflux condenser. The flask was flame-dried under high 
vacuum, resulting in a fine coating of iodine on the magnesium. The 
vessel was then placed under argon for the remainder of the reaction. 
Et2O (dried over Na wire) (10 mL) was added to the reaction 
vessel.  Subsequently, bromobenzene (0.99 mL, 1.47 g, 9.35 mmol, 
1.2 equiv) was added dropwise ensuring the reaction occurred at a 
constant rate.  When the addition was complete, the reaction was 
stirred until all activity subsided.  The solution of Grignard reagent, 
PhMgBr, was then quantitatively transferred in a dry, gas-tight 
syringe to a clean oven-dried 3-neck flask, attached to a reflux 
condenser.   
Subsequently, dry THF (20 mL) was added to the PhMgBr 
solution.  CS2 was added drop wise using a dry glass syringe and 
needle, and the solution became dark red-brown. After the addition 
was complete, the reaction was heated to 50 °C for 30 min to ensure 
full conversion. A solution of prop-2-ynyl 2-bromo-2-phenylacetate 
(1.98 g, 7.79 mmol, 1 equiv) in dry THF (20 mL) was then added to 
the reaction vessel.  The flask was covered with Al foil to minimize 
degradation of the product by light and stirred at 80 °C for 15 hours 
and subsequently the solvent was removed under vacuum.  
Purification by column chromatography (50% CHCl3/50% n-hexane) 
gave the acetylene RAFT agent 5 as a red oil (0.92 g, 2.81 mmol, 38 
%); FT-IR ATR (cm-1): 2920, 1691, 1588, 1463, 1443; 1H NMR 
(400 MHz, CDCl3) δ ppm 2.52 (1H, t, J = 2.3 Hz, C≡CH), 4.73 (1 
H, dd, J = 2.3 and 15.3 Hz, HCHC≡CH), 4.84 (1 H, dd, J = 2.3 and 
15.3 Hz, HCHC≡CH), 5.77 (1H, s, SCHPh), 7.36-7.61 (8H, m, 
ArH), 8.00-8.06 (2H, m, ArH)  13C NMR (100 MHz, CDCl3) δ ppm 
53.6 (alkyl C), 58.6 (alkyl C), 75.7 (C≡C), 76.9 (C≡C), 127.0 (ArC), 
128.5 (ArC), 128.9 (ArC), 129.1 (ArC), 129.2 (ArC), 132.6 (ArC), 
132.9 (ArC), 143.8 (ArC), 168.2 (C=O), 225.7 (C=S). 
 
 Synthesis of poly(PEGMA) 7 using the acetylene RAFT agent 5 
The acetylene RAFT 5 agent was used to synthesize a PEGMA 
polymer by RAFT polymerization as follows:  Poly(ethylene glycol) 
methacrylate 6 (Mn=475, PEGMA) (3 g, 6.32 mmol) was weighed 
into a Schlenk flask, then benzene (3.3 g) was added.  2,2’-
Azobisisobutyronitrile (AIBN) (12.9 mg, 0.078 mmol) was added to 
the flask, along with the RAFT agent 5 (257.1 mg, 0.789 mmol) 
([PEGMA]:[RAFT]:[AIBN] = 8:1:0.1).  The mixture was purged 
under argon for approximately 15 minutes then sealed and placed in 
an oil bath at 70 °C for 15 h. Crude samples were taken from the 
mixture and characterized by NMR and GPC analysis to ascertain 
full monomer conversion and molecular weight. The resulting 
polymer was dissolved in a small amount of DCM and purified by 
precipitation into cold diethyl ether.  The ether was then removed by 
decantation to give the polymer 7 as a pink gum. Further NMR and 
GPC analysis of the polymer 7 confirmed the removal of the starting 
materials (NMR in Figure S1 and S2 of the supporting information); 
(GPC: Mn = 7800, Mw = 8600, Mw/Mn = 1.10). 
 
Synthesis of 4-(5-Azidopentyl)tetrahydro-1H-thieno[3,4-
d]imidazole-2(3H)-one 4 
Synthesis of Ethyl [(3aS,4S,6aR)-2-oxo-hexahydro-thieno[3,4-
d]imidazol-4-yl]pentanoate (9)  
Biotin 8 (1.0 g, 4.09 mmol) was dissolved in absolute ethanol (25 
mL) and the resulting solution was acidified by adding several drops 
of conc. H2SO4.  The reaction mixture was stirred at room 
temperature for 16 h, after which the volatiles were removed under 
reduced pressure. The crude product was taken up in DCM (50 mL), 
and washed with saturated NaHCO3 (3 × 30 mL) and H2O (2 × 30 
mL).  The organic layer was dried (Na2SO4) and the solvent was 
removed under reduced pressure to give a white solid. 
Recrystallisation from cold acetone gave ethyl [(3aS,4S,6aR)-2-oxo-
hexahydro-thieno[3,4-d]imidazol-4-yl]pentanoate (9) as a white 
crystalline solid (0.82 g, 3.01 mmol, 74 %). FT-IR ATR: 3236, 
2926, 2861, 1731, 1709, 1478, 1284 cm-1; 1H NMR (400 MHz, 
CDCl3) δ ppm 6.00 (s, 1H), 5.61 (s, 1H), 4.53-4.43 (m, 1H), 4.32-
4.24 (m, 1H), 4.09 (q, J = 7.13 Hz, 2H), 3.25-3.03 (m, 1H), 2.88 (dd, 
J = 12.80, 4.96 Hz, 1H), 2.71 (d, J = 12.78 Hz, 1H), 2.30 (t, J = 7.50 
Hz, 2H), 1.77-1.54 (m, 4H), 1.52-1.33 (m, 2H), 1.23 (t, J = 7.13 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ ppm 173.686, 163.744, 61.931, 
60.284, 60.101, 55.443, 40.530, 33.933, 28.328, 28.220, 24.781, 
14.232; HRMS mass calculated for C13H23N2O3S
+: 273.1195 
experimental ESI [M+H]+: 273.1273. 
 
Synthesis of 4S-[(3aS,6aR)-5-Hydroxy-pentyl]-tetrahydro-
thieno[3,4-d]imidazol-2-one (10) 
Biotin ethyl ester 9 (200 mg, 0.733 mmol) was dissolved in DCM 
(0.7 mL) and placed under argon and cooled to -78 °C (dry 
ice/acetone). Diisobutylaluminium hydride (DIBAL) (1.72 mL, 2.5 
mmol, 1.5 M in toluene) was added dropwise over 10 minutes. The 
mixture was stirred at -78 °C for a further 20 minutes then allowed 
to warm to room temperature and stirred for 16 h. The mixture was 
again cooled to -78 °C and quenched by dropwise addition of 
methanol, a mixture of methanol and water and finally water. The 
solvents were removed under reduced pressure and the product was 
extracted with ethanol using a Soxhlet apparatus.  Subsequently the 
EtOH was removed under reduced pressure to give an off white 
solid.  Purification by column chromatography (50 % EtOAc/50 % 
EtOH) gave 4S-[(3aS,6aR)-5-hydroxy-pentyl]-tetrahydro-thieno[3,4-
d]imidazol-2-one (10) as a white solid (119 mg, 0.517 mmol, 71 %); 
FT-IR ATR: 3244, 2931, 2369, 1700, 1477cm-1; 1H NMR (400 
MHz, MeOH-d4 6.62 (s, 1H), 6.58 (s, 1H), 4.56-4.46 (m, 1H), 4.35-
4.29 (m, 1H), 3.57 (t, J = 6.50, 6.50 Hz, 2H), 3.27-3.19 (m, 1H), 2.95 
(dd, J = 12.76, 4.98 Hz, 1H), 2.72 (d, J = 12.72 Hz, 1H), 1.91 (s, 
1H), 1.83-1.35 (m, 1H); 13C NMR (100 MHz), MeOH-  
161.7, 62.0, 61.5, 55.8, 39.6, 33.5, 32.0, 28.8, 28.4, 25.5. HRMS 
mass calculated for C10H19N2O2S
+: 231.1089 experimental ESI 
[M+H]+: 231.1167. These data were found to have some discrepancy 
compared with those reported in literature.28, 29 It is suggested that 
some of the NMR data may have been misreported as the product 
reported in literature was not purified after the Soxhlet extraction.  
  
Synthesis of 4S-[(3aS,6aR)-5-(4-toluenesulfonyl)pentyl]-tetrahydro-
thieno[3,4-d]imidazol-2-one (11a) (4S-[(3aS,6aR)-5-chloropentyl]-
tetrahydro-thieno[3,4-d]imidazol-2-one (11b)) 
Biotinol 10 (119 mg 0.57 mmol) was dissolved in warm 
anhydrous pyridine (2.5 mL) under argon.  This solution was cooled 
in an ice bath for 30 minutes after which p-toluenesulfonyl chloride 
(120 mg, 0.63 mmol, 1.1 equiv.) was added.  After stirring at 0 °C 
for 5 minutes the reaction mixture was allowed to warm to RT and 
was stirred for a further 16 h.  The mixture was poured into cold 
water (~50 mL)  and extracted with DCM (3 × 50 mL).  The DCM 
solutions were then washed with 1.8 M H2SO4 (3 × 50 mL).  The 
aqueous layers were extracted with additional DCM (2 × 150 mL). 
The DCM layers were combined and subsequently washed with 
brine (3 × 100 mL) and dried over Na2SO4.  The solvent was 
removed and the obtained solid was purified by column 
chromatography (1:20 MeOH:DCM). NMR and MS characterisation 
of the obtained product indicated the presence of both tosyl 11a and 
chloro 11b functionalised biotin (60 mg, 19 % 11a, 16 % 11b 
(concentrations from NMR), 0.2 mmol, 35 % overall yield). Further 
attempts to separate these proved unsuccessful and the mixture was 
used in subsequent steps without additional purification.  
Tosylate 11a 1H NMR (400 MHz, CDCl3 ) δppm 7.79 (d, 2H, 
J=8.1 Hz), 7.36 (d, J=8.1 Hz, 2H),  6.34 (s, 1H), 5.65 (s, 1H), 4.56-
4.50 (m, 1H), 4.03 (t, J = 6.4 Hz, 2H), 3.22-3.07 (m, 1H), 2.94-2.87 
(m, 1H), 2.76 (d, J = 5.7 Hz, 1H), 2.46 (s, 3H), 1.83-1.30 (m, 8H); 
13C NMR (100 MHz, CDCl3) δ ppm 163.9, 144.7, 133.0, 129.8, 
127.8, 77.2, 70.6, 60.0, 55.6, 28.5, 28.3, 28.3, 25.3, 21.6; HRMS 
calculated for tosylate C17H24N2O4S2: 384.12 experimental ESI 
[M+H]+: 385.1256; 
Chloride 11b 1H NMR (400 MHz, CDCl3) δ ppm 6.05 (s, 1H), 
5.73 (s, 1H), 4.36-4.30 (m, 1H), 3.54 (t, J = 6.7 Hz, 2H), 3.22-3.07 
(m, 1H), 2.96-2.87 (m, 1H), 2.73 (d, J = 5.7 Hz, 1H), 1.54-1.31 (m, 
8H); 13C NMR (100 MHz, CDCl3) δppm 163.8, 61.9, 60.0, 55.5, 
45.0, 40.5, 32.2, 28.4, 28.2, 26.7; HRMS calculated for chloride 
C10H17N2SOCl: 248.0750 experimental ESI [M+H]
+: 249.0828. 
These data agree with both biotin tosylate and biotin chloride.28, 30  
 
Synthesis of 4-(5-Azidopentyl)tetrahydro-1H-thieno[3,4-
d]imidazole-2(3H)-one 12 
To the biotin tosylate/chloride mixture 11 (60 mg, 0.2 mmol) and 
sodium azide (32 mg, 0.6 mmol, 3.2 equiv.) was added to DMF (0.5 
mL).  The resultant solution was heated at 100 °C for 5 hours. The 
reaction mixture was cooled and water was added forming a white 
precipitate. Filtration of the precipitate gave 4-(5-
azidopentyl)tetrahydro-1H-thieno[3,4-d]imidazole-2(3H)-one 12 (30 
mg, 0.117 mmol, 62 %) mp: 85 °C; FTIR ATR showed a 
characteristic azide peak at 2100 cm-1; (400 MHz, CDCl3) δ ppm 
1.55-1.36 (m, 4H), 1.85-1.57 (m, 8H), 2.76 (d, J = 12.81 Hz, 1H), 
2.95 (dd, J = 12.84, 5.05 Hz, 1H), 3.22-3.15 (m, 1H), 3.29 (t, J = 
6.83, 6.83 Hz, 2H), 4.38-4.29 (m, 1H), 4.57-4.50 (m, 1H), 5.21 (s, 
1H), 5.47 (s, 1H); 13C NMR (100 MHz, CDCl3) δ ppm 163.3, 62.1, 
60.1, 55.5, 51.4, 40.6, 28.6, 28.6, 26.7; HRMS mass calculated for 
C10H18N5OS
+: 256.1154 experimental ESI [M+H]+: 256.1232. 
 
Gold Nanoparticle Synthesis  
Gold nanoparticles were prepared as we reported previously,8 via 
adaption of the method reported by Grabar et al.31 
Briefly, an aqueous solution of chloroauric acid (HAuCl4) (100 
mL, 1.0 mM) was heated to boiling, after which an aqueoussolution 
of sodium citrate (3.5 mL, 38.8 mM) was added. To ensure complete 
reduction, the solution was boiled for a further 15 min. The reaction 
was cooled to room temperature and stored as an aqueous suspension 
of AuNPs. All characterization data was consistent with that reported 
previously.8 
 
Polymer Biotin Conjugation 
The copper-catalyzed azide-alkyne cycloaddition (CuAAC) was 
first performed in water to test the reaction, since it is reported to 
proceed more readily in aqueous media. Both 1H NMR and FTIR-
ATR were used to monitor the disappearance of the azide 
functionality.  These reactions were performed with an excess of the 
acetylene coupling partner (in this case the PEG homopolymer 2) to 
ensure complete conversion of the azide.  
 
Preparation of biotin functionalized AuNPs: CuAAC of 
hybrid gold polymer nanoparticle with biotin azide.  
The poly(PEGMA) 7 (74 mg) was dissolved in 1 mL water.  
Biotin azide 4 (1.1 mg) was added to the vial, from an 11 mg/1 mL 
solution.  The reagents were made up to 1 mL each (13 mg 
CuSO4·5H2O and 16 mg of sodium ascorbate respectively) into 
water so that 100 µL could be added to the vial and the reaction(s) 
stirred for 24 hours.  Purification was conducted by centrifugation. 
Approximately 1mL AuNPs solution was placed in a clean vial.   
The biotin polymer product (100 µL) was added to the AuNPs and 
followed approximately 60 seconds later by 5, 10 or 200 µL of a 54 
µM solution of 2-quinolinethiol (QSH) and the resultant mixture was 
stirred overnight, to allow the QSH to penetrate into the polymer. 
The reaction was monitored for completion using ATR-IR with a Ge 
crystal.  
Approximately 1 mL of AuNP solution was placed in 10 separate 
vials, so that reproducibility could be ascertained.  Poly(PEGMA)13 
(35 mg) was dissolved in water (10 mL).  Subsequently, 0.5 mL of 
the polymer solution was added to the AuNP vial.  This was shaken 
and then set aside for an hour to allow attachment of the polymer to 
the nanoparticle surface.  Stability of the AuNPs was assessed by the 
addition of NaCl to a vial of the hybrid AuNPs (not incorporating 
biotin) and to a vial of citrate stabilised AuNPs. 
 
Demonstration of binding to streptavidin.  
The SigmaScreen™ Streptavidin High Capacity Coated Plates 
were obtained from Sigma Aldrich. The AuNP/biotin-conjugate 
polymer 5 solution (200 µL, as prepared) was added to each well on 
the well plate. The well plates were left to rest at RT for at least 2 
hours and then washed vigorously with PBS and 5 % tween 20 to 
remove any unbound material. SERS was used to analyse the 
presence of a signal to indicate the binding event.   
The biotin was added to a well plate that had been pre-treated 
with streptavidin.  Instructions supplied by Sigma with the well plate 
meant that approximately 200 µL of the AuNP/biotin solution 
needed to be added to individual wells on the well plate. This was 
left at RT for at least 2 hours then washed vigorously with PBS 
(phosphate buffered saline) and 5 % tween 20 (mild surfactant). The 
streptavidin solutions for this study were prepared at a concentration 
of 5 × 10-6 M in 0.5 M aqueous NaCl. 
The SERS signal of solution and plate was examined before and 
after washing.  Control samples were also analysed, using AuNPs 
with a SERS tag but no biotin attached.  Wells were prepared using 
the above procedure except without any biotin present. 
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